AG
CCXI

Algert Global’s ChemoCentryx, Inc. CCXI Stock Holding History

Algert Global’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,455
Closed -$1M – 1342
2022
Q3 		$1M Sell
19,455
-41,420
-68% -$1.71M 0.06% 542
2022
Q2 		$1.51M Buy
60,875
+46,740
+331% +$1.03M 0.11% 296
2022
Q1 		$354K Buy
+14,135
New +$397K 0.02% 927
2020
Q2 		– Sell
-7,669
Closed -$308K – 526
2020
Q1 		$308K Buy
+7,669
New +$326K 0.13% 246
2019
Q4 		– Sell
-34,460
Closed -$234K – 454
2019
Q3 		$234K Buy
34,460
+6,600
+24% +$49.5K 0.09% 253
2019
Q2 		$259K Buy
27,860
+15,334
+122% +$178K 0.1% 244
2019
Q1 		$174K Sell
12,526
-65,145
-84% -$745K 0.1% 254
2018
Q4 		$847K Sell
77,671
-24,610
-24% -$260K 0.24% 147
2018
Q3 		$1.29M Buy
102,281
+6,497
+7% +$78.3K 0.28% 132
2018
Q2 		$1.26M Buy
+95,784
New +$1.15M 0.26% 140

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Algert Global's CCXI Position: Q4 2022 in Review

Algert Global sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 19,455 shares — an estimated $1M sold.

Algert Global first reported a position in CCXI in Q2 2018 and held it in 10 quarters. The position peaked at $1.51M in Q2 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Algert Global reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 19,455 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1M.
  • Algert Global first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 10 quarters.
  • Algert Global's ChemoCentryx, Inc. position peaked at $1.51M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.